AUCTORES
Globalize your Research
Case Report | DOI: https://doi.org/10.31579/2692-9392/068
*Corresponding Author: Krivuš Juraj MD, University Hospital, Kollárova 2, 03601 Martin, Slovakia.
Citation: Gombošová Laura, Krivuš Juraj, Lazúrová Ivica, Dedinská Ivana, Mokáň Marián., (2021) Early effectivity of Teduglutide for the Treatment of short bowel Sydrome – our first Clinical experience. J. Archives of Medical Case Reports and Case Study, 4(4); DOI:10.31579/2692-9392/068
Copyright: © 2021 Krivuš Juraj, This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 28 June 2021 | Accepted: 14 July 2021 | Published: 19 July 2021
Keywords: short bowel syndrome; teduglutide; glucagon like peptide 2; home parenteral nutrition
Background
Short bowel syndrome is an uncommon malabsorptive condition most frequently caused by massive surgical resection of the small intestine. Standard of care is home parenteral nutrition. Teduglutide, glucagon like peptide 2 analog, was approved to treat patients with short bowel syndrome, who are stable following a period of post-surgery intestinal adaptation.
We report two cases of patients with short bowel syndrome on home parenteral nutrition, treated with teduglutide, novel advanced therapy. We monitored the effectiveness and tolerance of the new treatment.
Teduglutide increases intestinal absorption, causes cryptal hyperplasia, villous hypertrophy, angiogenesis, and allows weaning from parenteral nutrition. We confirmed the early onset of treatment effectiveness in the 4th month. Early effectiveness of treatment allowed a reduction in the volume of home parenteral nutrition with an improvement in quality of life.
Short bowel syndrome (SBS) is an uncommon malabsorptive condition most frequently caused by massive surgical resection of the small intestine ue to Crohn´s disease, mesenteric ischemia, adhesive ileus or traumatic conditions. [1, 2]. SBS is associated with significant morbidity and mortality, reduced quality of life, and high healthcare costs. [1]. The clinical manifestations are only partially related with the length of the resected intestine. It depends on the abillity of the residual gastrointestinal tract to compensate the resected part and to adapt functionally to the new anatomical condition [2]. SBS belongs to intestinal failure, defined as the reduction of the gut function below the minimum necessary for the absorption of macronutrients and/or water and electrolytes. [2]. Home parenteral nutrition (HPN) is the primary life-saving therapy for patients with chronic intestinal failure due to benign and malignant diseases [3]. Chronic IF treated with HPN may be associated with life-threatening complications of either the underlying disease or HPN, the latter accounting for around 14% of total deaths such as venous catheter-related complications and intestinal failure associated liver disease. [4]. Novel therapy of SBS is teduglutide, recombinant analog of enteral hormone glucagon-like peptide 2. It promotes intestinal growth, facilitates natrium recirculation, considered the primary mechanism by which many nutrients such as sugars and amino acids are absorbed. Therapy with teduglutide allows weaning from HPN with enteral autonomy onset. [5]. In a phase-III trial on adults with SBS dependent on HPN, a significantly greater proportion of patients taking 0.05 mg/kg/day teduglutide than placebo recipients achieved a ≥20% reduction in weekly HPN volume from baseline to week 20 and maintained it to week 24. [6]. Teduglutide is contraindicated in patients with active gastrointestinal malignancy, including those with nongastrointestinal malignancies. [6, 9]. Colonoscopic examination and removal of any colorectal polyps is recommended within 6 months prior to initiation of teduglutide. Subsequently, surveillance colonoscopy is recommended at the end of 1 year and then every 5 years or more frequently as needed. [7]. The aim of the article is to demonstrate the early efficacy of teduglutide with adjustment of weaning from parenteral nutrition.
Patient information, 1.st case
Patients history: a 54-year-old woman without a relevant medical history suffered a car accident in 2016. The result was severe destructive injury to the skeleton and abdominal organs. She underwent surgery with small and large bowel resection ileostomy with no colon-in-continuity was constructed, I.type of short bowel syndrome. The rest of the small intestine is about 60 cm, resection of the large intestine with the rest 40 cm, blinded.
We indicated HPN and hydratation: all in one nutrition bag with 1710 kcal/1075 ml for 10 hours daily in the week (7/7), 1000 ml of balanced salt solution 7/7 via Hickmans catheter and medication to slow the passage through the digestive tract and reduce the secretion of digestive juices.
The woman experienced several complications in a short time. The first one was thrombosis of un upper hollow vein and the internal jugular vein, in January 2017. The catheter had to be extracted and immediately inserted into the femoral vein, low molecular heparin treatment was recomended. After partial recanalization of the affected vessels Hickmans catheter was inserted into the left subclavian vein. Next complication was recurrent catheter sepsis (blood cultivation for Staphylococcus aureus), with preserved catheter treated with amoxyciline clavulanate, in 2018. Within two years, there was a partial adaptation of the intestine with reduced infusions form 7/7 to 5/7. In 2020, patient developed spondylodiscitis leading to the need to increase HPN to 7/7 plus 5/7 rehydration therapy.
Indication for teduglutide: after the antibiotic therapy of spondylodiscitis was patient indicated for the treatment with teduglutide with daily dose 0.26 ml (2,6 mg) subcutaneously. During therapy, we noted the prolapse of the stoma without further progression. The patient complains of fatigue, anorexia, bloating, stomach hardening. After changing the dosing time to the evening, the patient has no problems. After 20 weeks of treatment, we gradually reduced HPN more than 35% and total parenteral substitution by 25.6%. Patient requires HPN only 3 times a week rehydratation support as she needed. The patient´s is laboratory results are stabile.
Outcomes of treatment: after 20 weeks, we evaluated the treatment as effective. At 40.th week of treatment, the patient could be completely weaned from parenteral support. Oral feeding was effective. The patient's quality of life has significantly improved. She is not dependent on infusions, she can eat normally.
Case presentation
Patient information, 2.nd case
Patients history: 59 years old man with negative medical history was suffered from adhesive ileus, in 2017 year. Histological examination confirmed fibrinous purulent visceral peritonitis of unclear etiology. The condition required urgent surgical treatment, subtotal intestinal resection (60 cm rest of small intestine) with right sided hemicolectomia was performed. Type II. short bowel syndrome has developed, without ostomy, with colon in continuity.
Home parenteral nutrition 1500 kcal together with 1000 ml of balanced solutions was started. Parenteral nutrition with oral hyperphagia 2500 kcal daily was combined, with metabolic and water homeostasis, without complications, without weight loosing. After two years (in 2019) recurrent catheter-related sepsis was diagnosed (Stafylococcus aureus). Sepsis was treated with antibiotics and catheter replacement. The patient works full time and HPN with daily infusion regime is limiting for him.
Indication for teduglutide therapy: treatment with glukagon like peptide 2 analog was indicated (in the time of teduglutide registration in our country, in November 2020). Screening colonoscopy is a mandatory examination before teduglutide treatment. Colonoscopy revealed tubulovilous adenomatous polyp, endoscopic polypectomy was performed. Teduglutide dose adjusted to weight was 0,32ml/3,2 mg once daily, subcutaneously. Abdominal pain and bloating occurred during the first month of treatment, with resolution later. In the fifth month of treatment we registered a reduction in diarrhea (from 7 to 3 bowel movements), stool thickening, increased diuresis without oedemas.
Outcomes of treatment: Reduction of the volume of parenteral substitution was possible from 7/7 to 4/7 (43% reduction) with balanced water and mineral homeostasis. We anticipate further reduction of parenteral support with possible weaning from HPN and improving the quality of life. Also in this patients we evaluate the treatment as effective. At 28 weeks of treatment, it was possible to further reduce the parenteral support to 3 infusions per week (regime 3/7, 58% reduction in parenteral substitution from the start of HPN). It is assumed that it will be possible to terminate parenteral feeding in a short time.
Teduglutide, glucagon like peptide 2 analog, was approved to treat patients with short bowel syndrome, who are stable following a period of post-surgery intestinal adaptation Teduglutide has demonstrated clinical effectiveness in real-world studies. [9]. Our first clinical experiences confirms the onset of early effectiveness of treatment, with mild self limited adverse events at the beginning. Both patients reported stool thickening, reduced bowel movements (reduced stoma output), loss of thirst, and increased diuresis. According real life experiences improved stool consistency and frequency, as well as the sensation of thirst, were identified as early clinical markers of response. [8]. Reductions in parenteral support requirements were accompanied by significant increases in mean villus height and crypt depth in this cohort as assessed by direct measurement of biopsies obtained during endoscopy [9]. HPN volume reductions were associated with improvements in quality of life scores for patients with short bowel syndrome treated with teduglutide [10]. During further treatment, we anticipate weaning our patients from HPN. This is a great advantage for a full time working patient. We preliminarily assess that teduglutide treatment is effective and safe for patients with short bowel syndrome. Hypertrophy of ostomy was not progressed. Integrated safety data for 222 person-years of exposure to teduglutide in four clinical trials demonstrated that teduglutide has a safety profile in adult patients with SBS–IF consistent with prior studies. [9]. Teduglutide was associated with a significantly increased risk of gastrointestinal stoma complication compared with placebo. Stoma enlargement was observed in clinical trials and in real-world clinical practice [9].
Treatment for short bowel syndrome is well advanced. An innovative treatment is teduglutide, which allows weaning from parenteral nutrition and relieves the patient of a large number of infusion bags and medical devices. In practice, we have confirmed the early onset of effectiveness of GLP2 treatment. Therapy is well tolerated, with mild adverse events (abdomen pain) in the start of therapy. Significantly improves the quality of life of patients.
LG and JK performed the data collection. LG drafted the initial manuscript. JK, ID reviewed and IL revised the manuscript. ID and MM contributed to the conception of the manuscript and interpretation of the data, critically reviewed and revised the manuscript. IL coordinated and supervised data collection, reviewed and revised the manuscript. All authors took care of the patient and approved the final manuscript as submitted and agree to be accountable for all aspects of the work. All authors read and approved the final manuscript.
Conflict of interests
Authors declare no conflicts of interest.
Availability of data and materials
All data supporting the findings of this article are included in the manuscript.
Abbreviations:
SBS – short bowel syndrome
HPN - home parenteral nutrition
IF- intestinal failure
7/7 – administration of i.v. nutrition 7 days a week
Ethics declarations
Ethics approval and consent to participate. Not applicable.
Consent for publication
Written informed consent was obtained from the patient’s legal guardians for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Competing interests
The authors declare that they have no competing interest to disclose.
Acknowledgements: Not applicable
Funding: No funding was secured for this study.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
